# Estrogen for Triple Negative Breast Cancer

> **NCT01083641** · PHASE2 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 17 (actual)

## Conditions studied

- Female Breast Cancer

## Interventions

- **DRUG:** Estradiol

## Key facts

- **NCT ID:** NCT01083641
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2013-06
- **Final completion:** 2015-03
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** did not meet efficacy goals after interim analysis
- **Last updated:** 2019-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083641, "Estrogen for Triple Negative Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01083641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*